Literature DB >> 33385031

Data describing the effects of potassium channels modulators on outward currents measured in human lymphoma cell lines.

Alberto Montalbano1, Cesare Sala1, Chiara Abrardo1, Nicoletta Murciano1, Farhad Jahanfar2,3, Massimo D'Amico2, Francesco Bertoni4,5, Andrea Becchetti6, Annarosa Arcangeli1.   

Abstract

In the present work, applying the whole-cell patch-clamp technique in voltage clamp mode, we have investigated the effects of different drugs, such as riluzole, Psora-4 and Tram-34, on the potassium currents in four human lymphoma cell lines. We focused on outward currents mediated by two potassium channels (Kv1.3 and KCa3.1), which are known to play a key physiological role in lymphoid cells. The currents were evoked by voltage ramps ranging from -120 mV to +40 mV and the conductance of the two potassium channels was measured between +20 mV and +40 mV, both in the absence and in the presence of the specific blockers Psora-4 (Kv1.3; 1 µM) and Tram-34 (KCa3.1; 1 µM). The effect of the latter was tested after KCa3.1 channels were activated by riluzole 10 µM. Taken together, these data could be useful as an indication of the functional characteristics of the potassium channels in human lymphomas and represent a starting point for the study of potassium conductance in cellular models of these tumors.
© 2020 Università degli Studi di Firenze. Published by Elsevier Inc.

Entities:  

Keywords:  Human lymphomas; KCa3.1; Kv1.3; Patch-clamp; Potassium channels

Year:  2020        PMID: 33385031      PMCID: PMC7772536          DOI: 10.1016/j.dib.2020.106668

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


  6 in total

1.  Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.

Authors:  Serena Pillozzi; Marika Masselli; Emanuele De Lorenzo; Benedetta Accordi; Emanuele Cilia; Olivia Crociani; Amedeo Amedei; Marinella Veltroni; Massimo D'Amico; Giuseppe Basso; Andrea Becchetti; Dario Campana; Annarosa Arcangeli
Journal:  Blood       Date:  2010-11-03       Impact factor: 22.113

2.  Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.

Authors:  Ananthakrishnan Sankaranarayanan; Girija Raman; Christoph Busch; Tim Schultz; Pavel I Zimin; Joachim Hoyer; Ralf Köhler; Heike Wulff
Journal:  Mol Pharmacol       Date:  2008-10-27       Impact factor: 4.436

3.  Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.

Authors:  Julia Vennekamp; Heike Wulff; Christine Beeton; Peter A Calabresi; Stephan Grissmer; Wolfram Hänsel; K George Chandy
Journal:  Mol Pharmacol       Date:  2004-06       Impact factor: 4.436

4.  The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells.

Authors:  Serena Pillozzi; Massimo D'Amico; Gianluca Bartoli; Luca Gasparoli; Giulia Petroni; Olivia Crociani; Tiziano Marzo; Angela Guerriero; Luigi Messori; Mirko Severi; Roberto Udisti; Heike Wulff; K George Chandy; Andrea Becchetti; Annarosa Arcangeli
Journal:  Br J Cancer       Date:  2017-11-21       Impact factor: 7.640

5.  The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma.

Authors:  Alberto Magi; Marika Masselli; Cesare Sala; Angela Guerriero; Pasquale Laise; Benedetta Puccini; Luigi Rigacci; Carla Breschi; Olivia Crociani; Serena Pillozzi; Annarosa Arcangeli
Journal:  Sci Rep       Date:  2019-06-13       Impact factor: 4.379

6.  Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant.

Authors:  H Wulff; M J Miller; W Hansel; S Grissmer; M D Cahalan; K G Chandy
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.